Induction of lipocortin 1 by topical steroid in rat skin
- PMID: 7980630
- DOI: 10.1016/0006-2952(94)90210-0
Induction of lipocortin 1 by topical steroid in rat skin
Abstract
Western blotting and densitometric analysis of extracts obtained from EDTA extraction of skin segments showed greater extracellular Lipocortin 1 (LC1) in skin sites from steroid-treated animals compared to that seen in matched vehicle treated animals. Extracellular LC1 was maximal 3 hr after steroid, less was found in skin after 6 hr and levels had returned to basal at 18 hr. Pre-treatment of rats with the glucocorticoid receptor antagonist RU38486 (20 mg/kg) prevented the steroid induction of extracellular LC1 at both the 3 and 6 hr time-points. Systemic treatment of rats with betamethasone sodium phosphate (0.1-1 mg/kg) showed that the induction of LC1 on the cell surface was both time- and dose-dependent. Oedema in rat skin caused by 5-hydroxytryptamine (5-HT), platelet activating factor (PAF) and zymosan activated serum (ZAS) was assessed using 125I-labelled human serum albumin. Following a 3 hr topical treatment with betamethasone-17-valerate the inflammatory activities of all of the tested stimuli were significantly attenuated demonstrating that at this time-point the topical steroid was biologically active. Topical steroid treatment of the skin resulted in a translocation of LC1 to the cell surface, which was maximal after a 3 hr period and was also temporally associated with the anti-inflammatory effect of these agents.
Similar articles
-
Steroid inhibition of oedema formation in the rat skin.Br J Pharmacol. 1992 Jul;106(3):628-31. doi: 10.1111/j.1476-5381.1992.tb14386.x. Br J Pharmacol. 1992. PMID: 1504745 Free PMC article.
-
Topical glucocorticoids inhibit neurogenic inflammation: involvement of lipocortin 1.Eur J Pharmacol. 1995 Sep 5;283(1-3):193-8. doi: 10.1016/0014-2999(95)00350-t. Eur J Pharmacol. 1995. PMID: 7498310
-
A study of systemic and topical effects of topical steroid application through the comparison of two application schedules.J Dermatol. 1990 Jan;17(1):28-33. doi: 10.1111/j.1346-8138.1990.tb01605.x. J Dermatol. 1990. PMID: 2329214
-
Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 2. Anti-inflammatory and anti-lymphocyte activities.Br J Dermatol. 1978 Dec;99(6):665-73. doi: 10.1111/j.1365-2133.1978.tb07061.x. Br J Dermatol. 1978. PMID: 737129
-
Cutaneous microdialysis. A new technique for the assessment of skin penetration.Curr Probl Dermatol. 1998;26:90-8. doi: 10.1159/000060579. Curr Probl Dermatol. 1998. PMID: 9597319 Review. No abstract available.
Cited by
-
Effect of annexin-1 on experimental autoimmune encephalomyelitis (EAE) in the rat.Clin Exp Immunol. 1998 Jan;111(1):198-204. doi: 10.1046/j.1365-2249.1998.00490.x. Clin Exp Immunol. 1998. PMID: 9472682 Free PMC article.
-
Endogenous Annexin-A1 Negatively Regulates Mast Cell-Mediated Allergic Reactions.Front Pharmacol. 2019 Nov 13;10:1313. doi: 10.3389/fphar.2019.01313. eCollection 2019. Front Pharmacol. 2019. PMID: 31798445 Free PMC article.
-
Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1.Biochem Pharmacol. 2009 Jun 15;77(12):1814-26. doi: 10.1016/j.bcp.2009.03.010. Epub 2009 Mar 24. Biochem Pharmacol. 2009. PMID: 19428336 Free PMC article.
-
Topical glucocorticoids and the skin--mechanisms of action: an update.Mediators Inflamm. 1998;7(3):183-93. doi: 10.1080/09629359891126. Mediators Inflamm. 1998. PMID: 9705606 Free PMC article. Review.
-
Anti-allergic cromones inhibit histamine and eicosanoid release from activated human and murine mast cells by releasing Annexin A1.PLoS One. 2013;8(3):e58963. doi: 10.1371/journal.pone.0058963. Epub 2013 Mar 18. PLoS One. 2013. PMID: 23527056 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
